Pathology/Lab Coding Alert

Reader Question:

Follow Payer Guidance for Colon Biopsy

Question: When our pathologist examines a colon biopsy from a screening colonoscopy (turned diagnostic), should we report the screening ICD9 Code or the pathology report findings as the diagnosis? Florida Subscriber Answer: The answer to your question may depend on the payer. Generally, you should report the diagnosis to the highest degree of certainty known at the time of billing, which would mean using the pathology report findings such as 211.3 (Benign neoplasm of other parts of digestive system; colon). Payers may differ: Depending on your Medicare contractor or other payer rules, you may need to list first the screening code (V76.51, Special screening for malignant neoplasms; colon) to show that the procedure started as a screening colonoscopy. Here's why: Although the pathologist uses the same charge code for a colon biopsy (88305, Level IV - Surgical pathology, gross and microscopic examination, colon, biopsy) without regard to whether the physician [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more